Evaluation of pharmacokinetic and pharmacodynamic drug interaction between Indinavir and repaglinide in normal, diabetic and hepatic impaired rats.
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: GOUD, Thirumaleswara (Creative Educational Society's College of Pharmacy, Pharmacy Practice, saraswathi nagar, India)
- Co-author(s): Thirumaleswara Goud: Pharmacy Practice, Creative Educational Society's College of Pharmacy, kurnool, India
Srinivasa Rao Maddi: DMPK, GVK Bioscience, HYDERABAD, India
Devanna N: Chemistry, Jawaharlal nehru technological university, anantapur, India
To evaluate the safety and effectiveness of repaglinide and indinavir in normal, diabetic and Hepatic Impairment rats.
The aim of this study is to investigate the pharmacokinetic drug interaction between repaglinide and indinavir.
Wistar albino rats were utilized for the study and they are divided into five groups, each group.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.